Dr. Reddy’s inks strategic pact with Biocodex

04 Nov 2015 Evaluate

Dr. Reddy’s Laboratories has entered into a strategic alliance with Biocodex to market and distribute Biocodex products in the Romanian market. Biocodex has announced the change in partnership and effective October 1, 2015, Dr. Reddy’s has been given the complete rights for promotion and distribution of the Biocodex products across Romania.

Earlier, AKACIA was in partnership with Biocodex for similar distribution pact. With this new collaboration coming into existence, Dr. Reddy’s will aim to develop the access of the Romanian patients to the Rx portfolio including Biocodex's well-known OTC products ENTEROL and OTIPAX.

ENTEROL is the ethical pharmaceutical specialty composed of lyophilised Saccharomyces boulardii living cells in a concentration of 250 mg per capsule, or per sachet registered in Romania in packs of 10 capsules and sachets under the trademark ENTEROL.

OTIPAX is the ethical pharmaceutical specialty presented as an ear drop solution containing phenazone and lidocaine hydrochloride, presented in bottles of 15 ml registered in Romania under the trademark OTIPAX.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1298.95 24.90 (1.95%)
20-Mar-2026 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1773.90
Dr. Reddys Lab 1298.95
Cipla 1262.60
Zydus Lifesciences 891.35
Lupin 2309.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×